NCT05571930

Brief Summary

Objective Complex aortic pathology has been revolutionized with the use of hybrid prostheses such as the Thoraflex® Hybrid Frozen Elephant Trunk (FET). The aim of this study was to evaluate the midterm results of secondary extension of the FET by thoracic endovascular aortic repair (TEVAR). Few data are present in the literature regarding the outcomes of this secondary treatment. The investigators perform a prospective study between 2015 and 2022 in a tertiary aortic center on all consecutive patients having undergone TEVAR after FET implantation. The TEVAR endograft covered most of the 10 cm FET module with 2 to 4 mm oversizing. All patients were monitored by computerized angiography (CTA) at 6-month and yearly thereafter. The aim of this study was the feasibility of theses secondary connexion and the mid term outcomes of the endovascular treatment.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2022

Completed
5 months until next milestone

First Posted

Study publicly available on registry

October 7, 2022

Completed
Last Updated

October 7, 2022

Status Verified

October 1, 2022

Enrollment Period

5 years

First QC Date

May 24, 2022

Last Update Submit

October 5, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Absence of endoleak after secondary connexion

    Absence of Type 1A endoleak

    yearly thereafter up to 5 years

Secondary Outcomes (2)

  • Feasibility of the secondary connexion

    During the surgery

  • Absence of endoleak after secondary connexion

    early thereafter up to 5 years

Interventions

Under general anesthesia, via percutaneous femoral access, the investigators implant a TEVAR in the endovascular part of a FET. This secondary connexion is indicated in case distal thoracic aortic involvement such as aneurysm or dissection.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with aortic cross replacement by FET who are indicated for a secondary connexion in emergency : Aortic type A dissection with organ malperfusion Defect in the expansion of the FET module or in chronical evolution: Type 1 and Type 2 Thoracoabdominal aneurysm (TAAA) with a diameter at \> 6 cm Aneurysmal evolution of the false lumen of a dissected aorta.

You may qualify if:

  • Patient with aortic cross replacement by FET and
  • Type 1 and Type 2 Thoracoabdominal aneurysm (TAAA) with a diameter at \> 6 cm or
  • an aortic dissection, Type A (TAAD) or Type B (TBAD) with either organ malperfusion due to compression of the true channel or aneurysmal evolution of the dissected aorta, or
  • A defect in the expansion of the FET module

You may not qualify if:

  • No aortic cross replacement by FET

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Aortic Dissection

Condition Hierarchy (Ancestors)

Dissection, Blood VesselAneurysmVascular DiseasesCardiovascular DiseasesAcute Aortic SyndromeAortic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Hostalrich Aurelien, MD

Study Record Dates

First Submitted

May 24, 2022

First Posted

October 7, 2022

Study Start

January 1, 2015

Primary Completion

January 1, 2020

Study Completion

January 1, 2022

Last Updated

October 7, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Data are anonymised in our local prospective database shared between all investigators.